Vanadate down-regulates cell surface insulin and growth hormone receptors and inhibits insulin receptor degradation in cultured human lymphocytes.

This publication has 48 references indexed in Scilit:

• Growth hormone receptor and serum binding protein: purification, cloning and expression
  Nature, 1987
• Vanadate stimulation of IGF binding to rat adipocytes
  Biochemical and Biophysical Research Communications, 1986
• Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose
  Cell, 1986
• Insulin receptors in isolated human adipocytes. Characterization by photoaffinity labeling and evidence for internalization and cellular processing.
  Journal of Clinical Investigation, 1983
• Insulin-like effect of vanadate on adipocyte glycogen synthase and on phosphorylation of 95,000 dalton subunit of insulin receptor
  Biochemical and Biophysical Research Communications, 1983
• Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate
  Biochemical and Biophysical Research Communications, 1982
• Vanadium — an element in search of a role
  Trends in Biochemical Sciences, 1980
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976
• Externally disposed plasma membrane proteins. I. Enzymatic iodination of mouse L cells.
  The Journal of cell biology, 1975
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970